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1  | INTRODUC TION
Genetic diversity is a key determinant of the ecology and evolution 
of host–pathogen systems. Various studies of wild organisms have 
shown that genetic diversity within a host species often affects 
pathogen prevalence. The importance of diversity for disease preva-
lence in wild populations has been observed in numerous species, for 
example: cheetahs (O'Brien et al., 1985); Italian agile frogs (Pearman 
& Garner, 2005); crimson rosella parrots (Eastwood et al., 2017); 
inbred black-footed ferret populations (Thorne & Williams, 1988); 
inbred California sea lions (Acevedo-Whitehouse, Gulland, Greig, & 
Amos, 2003); young island populations of deer mice (Meagher, 1999); 
and Galapagos hawks (Whiteman, Kimball, & Parker, 2007). The im-
portance of diversity for limiting disease in agricultural contexts 
has long been recognized (Elton, 1958), for example in rice (Zhu 
et al., 2000) and hybridizing populations of honeybees (López-
Uribe et al., 2017). In laboratory environments, more genetically di-
verse populations of Daphnia magna are more resistant to parasites 
(Altermatt & Ebert, 2008), an effect that depends on the genetic ar-
chitecture of resistance (Luijckx, Fienberg, Duneau, & Ebert, 2013). 
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Abstract
Diversity in host resistance often associates with reduced pathogen spread. This 
may result from ecological and evolutionary processes, likely with feedback between 
them. Theory and experiments on bacteria–phage interactions have shown that ge-
netic diversity of the bacterial adaptive immune system can limit phage evolution 
to overcome resistance. Using the CRISPR–Cas bacterial immune system and lytic 
phage, we engineered a host–pathogen system where each bacterial host genotype 
could be infected by only one phage genotype. With this model system, we explored 
how CRISPR diversity impacts the spread of phage when they can overcome a re-
sistance allele, how immune diversity affects the evolution of the phage to increase 
its host range and if there was feedback between these processes. We show that 
increasing CRISPR diversity benefits susceptible bacteria via a dilution effect, which 
limits the spread of the phage. We suggest that this ecological effect impacts the 
evolution of novel phage genotypes, which then feeds back into phage population 
dynamics.
K E Y W O R D S
CRISPR–Cas, dilution effect, evolutionary emergence, experimental evolution, host–pathogen, 
phage, Pseudomonas aeruginosa
2  |     COMMON et al.
In microbial systems, Pseudomonas aeruginosa PA14 and Streptococcus 
thermophilus with diverse immunity alleles were shown to be more 
resistant against lytic bacteriophage (Morley, Broniewski, Westra, 
Buckling, & van Houte, 2017; van Houte et al., 2016). Two recent me-
ta-analyses have shown that host diversity is a robust defence against 
pathogens both in agricultural (Reiss & Drinkwater, 2018) and natural 
populations (Ekroth, Rafaluk-Mohr, & King, 2019).
The suggested reasons for the effect of host diversity on patho-
gen spread can be broadly divided into ecological and evolutionary 
effects. The ecological effect of diversity may manifest through a di-
lution effect (Civitello et al., 2015; Ostfeld & Keesing, 2012). The dilu-
tion effect, in terms of within-species immune diversity, is suggested 
to arise because increasing the number of resistant or low-quality in-
dividuals in a host population decreases the proportion of susceptible 
individuals in that population. This can reduce contact rates between 
free-living pathogens and susceptible hosts, which in turn limits the 
basic reproduction number of the pathogen (R0) (Dobson, 2004; 
Gandon, 2004; Lively, 2010). There is much observational support for 
the role of a dilution effect in multi-species host–pathogen systems 
(reviewed in (Civitello et al., 2015)), and some experimental work has 
suggested that dilution of susceptible host genotypes can limit patho-
gen spread in single host species systems (Common & Westra, 2019; 
Dennehy, Friedenberg, Yang, & Turner, 2007). Evolutionary effects 
of diversity may manifest through limitation of the evolutionary 
emergence of novel pathogen genotypes (Ohtsuki & Sasaki, 2006; 
Sasaki, 2000). Importantly, however, the evolutionary and ecological 
effects of host diversity are interdependent as the basic reproductive 
value of a pathogen will influence its ability to evolve to overcome 
host resistance (Antia, Regoes, Koella, & Bergstrom, 2003). Because 
increasing host diversity dilutes susceptible hosts, pathogens may 
reach smaller population sizes and generate fewer novel variants on 
which selection can act (Antia et al., 2003; Dennehy, Friedenberg, 
Holt, & Turner, 2006; Yates, Antia, & Regoes, 2006). Simultaneously, 
increasing host diversity can increase selection for novel variants. 
These two effects can maximize evolutionary emergence at interme-
diate host diversity (Benmayor, Hodgson, Perron, & Buckling, 2009; 
Chabas, et al., 2018a).
The interaction between lytic bacteriophage (phage) and the 
bacterial CRISPR–Cas (Clustered Regularly Interspaced Short 
Palindromic Repeats; CRISPR-associated) immune system is a trac-
table model system to study the evolutionary ecology of infec-
tious diseases, including the role of host diversity (Chabas, et al., 
2018a; van Houte et al., 2016; Westra, Sünderhauf, Landsberger, 
& Buckling, 2017). CRISPR–Cas immune systems can incorporate 
short DNA fragments (spacers) of about 30 base pairs derived from 
the phage genome into CRISPR loci on the host genome (Horvath 
et al., 2008). Processed CRISPR transcripts guide Cas immune 
complexes to identify and cleave the invading phage genome, pre-
venting successful re-infections (Brouns et al., 2008; Datsenko 
et al., 2012; Garneau et al., 2010; Marraffini & Sontheimer, 2008; 
Westra et al., 2012). In turn, phage can evolve to overcome CRISPR 
immunity by point mutation in the sequence targeted by the spacer 
(protospacer) or in the protospacer-adjacent motif (PAM), which 
flanks the protospacer and functions in self/nonself-discrimina-
tion (Deveau et al., 2008; Mojica, Diez-Villasenor, Garcia-Martinez, 
& Almendros, 2009; Semenova et al., 2011; Westra et al., 2013). 
Phage evolution to overcome CRISPR immunity can lead to CRISPR–
phage coevolution (Common, Morley, Westra & van Houte,, 2019; 
Paez-Espino et al., 2013, 2015; Sun, Thomas, Barrangou, & 
Banfield, 2016). CRISPR loci in both natural and experimental popu-
lations can be highly diverse (Andersson & Banfield, 2008; Common 
et al., 2019; Paez-Espino et al., 2013; Westra et al., 2015), due to 
different bacteria in the population acquiring different spacers 
(Westra et al., 2017). Diversity has important implications for the co-
evolutionary interaction, as CRISPR diversity can provide increased 
resistance by limiting the ability of phage to acquire the mutations 
needed to overcome CRISPR immunity (Common et al., 2019; 
Morley et al., 2017; van Houte et al., 2016). Phage mutation is lim-
ited by mutation supply (Chabas, et al., 2018b; Lenski & Levin, 1985; 
Levin, Moineau, Bushman, & Barrangou, 2013), and full phage in-
fectivity requires mutations in all the protospacers targeted by the 
host CRISPR array. This becomes more difficult as individual- and 
population-level CRISPR diversity increases (Levin et al., 2013; van 
Houte et al., 2016), and can drive rapid phage extinction (Chabas, 
et al., 2018a; Morley et al., 2017; van Houte et al., 2016).
Apart from this evolutionary effect, theory predicts that even if 
a phage mutant evolved that can overcome one CRISPR resistance 
allele in the population, its ability to amplify will be reduced in a more 
diverse host population (Lively, 2010). The resulting smaller phage 
population sizes are in turn predicted to reduce the ability of the 
phage to evolve to overcome other CRISPR resistance alleles in the 
population (Antia et al., 2003; Chabas, et al., 2018a). However, these 
predictions remain untested. We therefore set out to explicitly test 
how host diversity could limit pathogen population size through a di-
lution effect, if and how this affects phage evolution, and the degree 
of interdependence between these processes. Using the bacteria 
Pseudomonas aeruginosa and its lytic phage DMS3vir, we performed 
an experiment where we manipulated the degree of CRISPR diver-
sity in the host population by mixing bacterial genotypes that each 
carried a different CRISPR spacer. We then infected these host pop-
ulations with a phage that was pre-evolved to infect only one host 
genotype. We then tracked changes in host fitness, and phage pop-
ulation dynamics and evolution, over 3 days.
2  | MATERIAL S AND METHODS
2.1 | Bacterial strains and phage
Evolution experiments were carried out using wild-type Pseudomonas 
aeruginosa UCBPP-PA14 (which has two CRISPR loci, CRISPR1 and 
CRISPR2), UCBPP-PA14 ∆pilA (this strain lacks the pilus, which is 
the phage DMS3 receptor, and therefore displays surface-based 
instead of CRISPR-based resistance) and phage DMS3vir (Zegans 
et al., 2009). We used P. aeruginosa UCBPP-PA14 csy3::lacZ (Cady, 
Bondy-Denomy, Heussler, Davidson, & O'Toole, 2012), which carries 
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an inactive CRISPR–Cas system, for phage amplification, and for top 
lawns in phage spot and plaque assays. P. aeruginosa PA14 csy3::lacZ, 
Escherichia coli DH5α (NEB), E. coli CC118 λpir (NEB) and E. coli 
MFDpir (Ferrieres et al., 2010) were used for molecular cloning.
2.2 | Co-culture experiment
To control the levels of CRISPR diversity in our evolution experi-
ments, we established a library of 24 P. aeruginosa PA14 clones each 
carrying a single spacer in CRISPR2 (bacteriophage-insensitive mu-
tants, BIMs). We also independently evolved 24 phage mutants that 
could infect each one BIM (escape phage).
We designed 5 treatments in which we manipulated the level of 
CRISPR spacer diversity, based on the BIM library: monocultures (1-
clone), or polycultures consisting of 3, 6, 12 and 24 clones. In order 
to monitor the population dynamics and relative fitness of individual 
bacterial clones within the polyculture treatments over the course 
of the experiment, we transformed 8 BIMs to carry a lacZ reporter 
gene. The lacZ gene encodes the β-galactosidase enzyme that hydro-
lyses X-gal, resulting in the production of a blue pigment. For each 
of the polyclonal treatments, a single BIM carrying the lacZ reporter 
gene was included. A total of 8 BIMs were chosen for transformation 
so that a single clone could be monitored in each of the 3-clone mix-
tures (BIMs 1, 4, 7, 10, 13, 16, 19 and 22; see Table S1).
From fresh overnight cultures of each BIM, we made mixes of 
equal proportion of each clone corresponding to the diversity treat-
ments. To monitor the population dynamics and competitive per-
formance of all bacterial clones with an active CRISPR system, we 
also added PA14 ∆pilA (which is fully resistant to phage DMS3vir via 
surface-based resistance and has a distinct “smooth” colony mor-
phology) to each mix in equal proportion to the CRISPR-carrying 
fraction of the population. We then inoculated 6 ml of M9 minimal 
media (supplemented with 0.2% glucose; M9m) with bacteria from 
the mixed overnight cultures at a dilution of 1:100. Approximately 
1 × 106 pfu/ml of the escape phage targeting the labelled BIM was 
then added to each vial. We also established 1- and 24-clone treat-
ments with ancestral phage as controls. Polyclonal treatments con-
sisted of 8 biological replicates (N = 8) to ensure that both BIMs and 
phage were equally represented across treatments, whereas the 
1-clone treatments consisted of 24 biological replicates (N = 24). 
Glass vials were incubated at 37°C while shaking at 180 rpm. At 1, 2 
and 3 days post-infection (dpi), the sampling of the phage and bac-
terial culture was repeated as described below. Cultures were trans-
ferred 1:100 to fresh media after sampling had been carried out. The 
experiment was terminated at 3 dpi.
Sampling proceeded as follows. Each day 180 μl of culture was 
taken from each vial and phage was extracted using chloroform. 
Phage titres were determined by serially diluting extracted phage 
in 1× M9 salts and then spotting 5 μl of each dilution on a top lawn 
of P. aeruginosa PA14 csy3::lacZ, which was then incubated at 37°C 
for 24 hr. Phage titres were calculated from this assay. The detec-
tion limit of phage spot assays is 102 pfu/ml. To monitor bacterial 
densities, culture samples were serially diluted in 1× M9 salts, and 
then plated on LB agar + 40 µg/ml X-gal + 0.1 mM IPTG, and incu-
bated for 48 hr at 37°C. The density of SM, CRISPR and the labelled 
BIM was then calculated. SM was differentiated from CRISPR clones 
by their “smooth” colony morphology, and the labelled BIM was 
identified by the blue:white screen.
We assessed the competitive performance of the all BIMs rela-
tive to the ∆pilA strain, and the labelled BIM relative to nonlabelled 
BIMs by calculating selection rate (r) each day (t) from 1 to 3 (n) dpi 
(rn = (ln [density strain A at tn/density strain A at tn−1] − ln[density 
strain B at tn/density strain B at tn−1])/day) (Lenski, 1991; Travisano & 
Lenski, 1996), which expresses competitive performance as the nat-
ural log of the relative change in density of one competitor against 
another. We decided to calculate selection rate instead of relative 
fitness (W) as used in Westra et al. (2015), because W is very sen-
sitive to starting densities and hence becomes increasingly skewed 
at later time points. Applied to our data, it consequently produced 
impossibly high values.
2.3 | Phage evolution
We examined phage evolution during the experiment by sampling 12 
individual plaques from each replicate that had detectable levels of 
phage from 1 to 3 dpi, which were amplified on PA14 csy3::lacZ over-
night in LB, at 37°C and shaking at 180 rpm. Phage was extracted 
using chloroform and then diluted 1,000-fold. Samples of each 
phage were then applied on lawns of each of the 24 BIMs and PA14 
csy3::lacZ. A successful infection was indicated by a clear lysis zone 
on the top lawn. Phage was classified according to whether they had 
expanded their infectivity range (could infect the original susceptible 
clone and a new clone in the BIM library). Of the phages that had 
undergone a host shift (lost infectivity to the original clone and could 
only infect a new clone), we confirmed their expanded infectivity 
range by sequencing the old and new protospacers on the evolved 
phage genome (SourceBioscience). We also sequenced the relevant 
protospacers of the pre-evolved escape phage from the BIM-phage 
library and ancestral DMS3vir. Primers are given in Table S3.
2.4 | Statistical analyses
All statistical analyses were carried out in R v3.5.3 (R Core Team, 
2018). Generalized linear mixed models (GLMMs) were used 
throughout, and replicate was treated as a random effect in all 
models. Days post-infection (dpi) was treated as a continuous vari-
able and CRISPR allele diversity as a categorical variable. Model 
selection followed a nested approach, where full versus reduced 
models were compared using information criteria (Burnham & 
Anderson, 2003, 2004), as well as focussed comparisons of ob-
served and predicted values. The overall statistical significance 
of the single and interaction effects of fixed effects (e.g. treat-
ment and dpi) was assessed using ANOVA, which gives an F- and 
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associated p-value. Simple Bayesian GLMMs from the MCMCglmm 
(Hadfield, 2010) package were used to analyse phage evolution to 
overcome model conversion issues encountered with this dataset. 
These models used a probit transformation (the inverse standard 
normal distribution of the probability) and a flat prior. The overall 
statistical significance of the single and additive effects of fixed 
effects in these models was assessed using Likelihood Ratio (LR) 
tests and their associated p-values using the VCVglmm package 
(Brown, 2019). Where possible, exact p-values are given, but R is 
unable to give exact values when p < 2.2 × 10–16. When phage 
titre was considered as the response variable, data were log-
transformed to improve model fit after adding 1 to every value. 
Credibility intervals around model coefficients and predictions 
were calculated to the 95%, 89% and 67% level to give the reader 
a clearer indication of effect size. All R code used for analyses 
and figures is available at this manuscript's GitHub—github.com/
JackCommon/Common_etal_2020.
3  | RESULTS
To explore how population-level immune diversity would influence 
the population dynamics and evolution of an infective phage and 
its susceptible host genotype, we first developed a library of 24 P. 
aeruginosa PA14 bacteriophage-insensitive mutants (BIMs), and a 
corresponding library of 24 DMS3vir mutants, each of which was 
pre-evolved to infect only one of the 24 host BIMs (escape phage; 
Figure 1a). We then set up an experiment where we mixed 1, 3, 6, 
12 or 24 BIMs, and inoculated each mixture with ~106 pfu/ml of a 
single escape phage (Figure 1b). Because this experimental design 
increases the proportion of resistant bacterial hosts whereas de-
creasing the proportion of the susceptible host (i.e. the one that 
could be infected by the escape phage) (Figure S1), it enables us to 
explicitly test how this dilution effect is related to the benefits of 
host CRISPR allele diversity. The susceptible clone always carried 
a lacZ reporter gene, so we could follow its population dynamics 
and competitive performance during the experiment (Figure 1b). 
P. aeruginosa ∆pilA, an isogenic mutant that does not have CRISPR 
immunity and resists phage infection via surface receptor modifica-
tion, was added to each host mixture (Figure 1b). P. aeruginosa ∆pilA 
was resistant to all phage and allowed us to compare the fitness of 
the CRISPR immune populations across the CRISPR allele diversity 
levels. We also included 1- and 24-clone treatments inoculated with 
ancestral phage to which the whole bacterial population was resist-
ant. These treatments allowed us to examine bacteria and phage 
dynamics at the two extremes of host diversity we tested in host 
populations with no pre-existing susceptibility. We then compared 
those dynamics with host mixtures that included a susceptible clone 
(van Houte et al., 2016; Figure 1b). We then monitored population 
dynamics and evolution of the phage, of the clones with CRISPR im-
munity, and the susceptible fraction of the CRISPR population over 
3 days.
We hypothesized that if CRISPR diversity limits phage epi-
demics, then phage density would be negatively correlated with 
CRISPR diversity. Phage densities decreased as CRISPR diversity 
increased (F6,342 = 48.30, p < 2.2 × 10
–16; Figure 2), phage popula-
tion sizes decreased over the course of the experiment (regression 
of ln plaque-forming units [pfu]/ml over days post-infection [dpi]: β 
[95% CI] = −1.32 [−1.74, −0.94], t(2)344 = −6.40, p = 5.06 × 10
–10), and 
phage declined faster with increasing CRISPR diversity (interaction 
between CRISPR diversity and days post-infection: F6,314 = 24.10, 
p < 2.2 × 10–16; Figure 2a,b). This is consistent with an effect of 
CRISPR diversity that protects the bacterial population from phage. 
Further, phage titre in the 1-clone treatment infected with ancestral 
phage [“1-clone (ancestral)” in Figure 2b] is statistically similar to that 
observed in the 1-clone treatment infected with an escape phage 
['Intercept' in Figure 2b], which is in line with previous data showing 
that monocultures composed of hosts with CRISPR immunity allow 
phage persistence due to rapid evolution of escape phage that over-
comes the CRISPR resistance allele (van Houte et al., 2016). The evo-
lution of escape phage in our monoculture treatments likely caused 
the observed fluctuations in the density of hosts with CRISPR immu-
nity (Figure S1). When we explored the model further, we found that 
phage titres in the 24-clone (ancestral phage) treatment were lower 
than the 24-clone treatment infected with escape phage (difference 
in ln pfu/ml: β [95% CI] = −2.40 [−4.67, −0.33], t(2)342 = −2.25, p = .03; 
Figure 2b). This is consistent with a modest epidemic being able to 
establish by replicating on the susceptible fraction of the host popu-
lation in the 24-clone treatment infected with escape phage.
Next, we hypothesized that if phage population size across our 
CRISPR diversity treatments was related to phage evolution, the 
proportion of phage that evolved an expanded infectivity range 
would correlate with CRISPR diversity. Given that our experiment 
was designed such that the proportion of the host population re-
sistant to the escape phage increased with CRISPR diversity, there 
would likely have been strong selection to acquire mutations in 
other protospacers and PAMs to infect other hosts in the popu-
lation. The evolution of range expansion did depend on diversity 
(Likelihood Ratio = 6.60, p = .01), and was most likely in the 6-clone 
treatment, particularly at 3 days post-infection (dpi) (Figure 3). This 
result suggests that intermediate host diversity in the 6-clone treat-
ment increased the likelihood that novel escape phage with an ex-
panded host range would evolve (Benmayor et al., 2009; Chabas, 
et al., 2018a). The fact that these novel phage could infect more 
hosts likely explains why phage population size was more consistent 
in the 6-clone compared to the 3-clone treatment (Figure 2a), and 
there was no significant difference in phage population size between 
these treatments (Figure 2b). Together, these data suggest that the 
increased likelihood of evolutionary emergence at intermediate host 
diversity balances against the potential limitation of reproduction 
caused by the dilution effect. These novel phage variants could then 
maintain phage population size.
Additionally, the presence of phage in some treatments was pro-
moted by evolution of a host shift, where infectivity on the original 
     |  5COMMON et al.
F I G U R E  1   Experimental design. (a) Infectivity matrix of the library of bacteriophage-insensitive mutants (BIMs) and escape phages. 
The identity of BIMs and escape phage (1–24) is shown in the first row and column, respectively. Black squares represent infectivity, and 
white indicates no infectivity. Infectivity of the wild-type DMS3vir is shown, as well as the infectivity of each escape phage on wild-type 
P. aeruginosa PA14. (b) Design of the co-culture experiment. The library of BIMs and escape phage is shown at the top. For each CRISPR 
allele diversity treatment, the relevant numbers of BIMs and escape phage were taken from the library and used to start the experiment, 
as shown by the arrows. The number of BIMs is shown next to the arrows. Blue text indicates that the BIM was engineered to carry a lacZ 
reporter gene and that it was susceptible to the escape phage. Black text indicates that the BIMs were resistant to the phage. The number of 
replicates (N) is given underneath each treatment. SM represents the surface mutant strain PA14 ∆pilA
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host is lost but phage evolved to infect a new host. This is a less likely 
event as it involves two mutations: back mutation to the ancestral 
state at the original protospacer followed by mutation at the new 
protospacer, all while incurring the cost of loss of infectivity on the 
original host. We observed phage in two of eight replicates of the 
24-clone treatment had evolved a host shift. Sequence data con-
firmed that single-nucleotide polymorphisms (SNPs) in the PAM that 
conferred infectivity to the original host had been lost, and novel 
SNPs or deletions had emerged in protospacers that conferred in-
fectivity to a new host present in the population (Tables S4 and S5 
in S1 Text). Recall that phage titres in the 24-clone (ancestral phage) 
treatment were lower than the 24-clone treatment infected with es-
cape phage (Figure 2b). Together with the presence of phage that 
evolved by host shift, these data suggest that the establishment of 
a modest phage epidemic in this treatment may have facilitated the 
evolutionary emergence of novel phage.
Given that CRISPR diversity negatively affected phage popula-
tion size, we expected that this would lead to enhanced fitness of 
all bacterial hosts with CRISPR immunity relative to hosts without 
CRISPR immunity (van Houte et al., 2016). This is because the fitness 
costs associated with CRISPR immunity are conditional upon phage 
exposure (Westra et al., 2015). We therefore hypothesized that the 
selection rate (Lenski, 1991; Travisano & Lenski, 1996) of all CRISPR 
clones (both resistant and susceptible) compared to the ∆pilA strain 
(which does not use CRISPR immunity) would be positively related to 
CRISPR diversity. Despite some variation among replicates, we did 
find that CRISPR clones in all polyclonal host populations had higher 
selection rates compared to clonal populations during infection with 
F I G U R E  2   Increasing CRISPR 
diversity limited phage population size. 
(a) Population dynamics of phage at 
different levels of CRISPR diversity in 
the host population (panels). Black lines 
show the phage density expressed as 
plaque-forming units (pfu) /ml in individual 
replicates at each day post-infection. 
The limit of phage detection is 200 pfu/
ml. (b) Coefficients from a GLMM of the 
natural log of phage density (ln[pfu/ml]), 
with CRISPR allele diversity treatment 
and days post-infection (dpi) as fixed 
effects. The intercept is the mean phage 
titre in the 1-clone treatment at 0 dpi. 
The β differences from the intercept 
(shown as a dotted line) are given for the 
remaining levels of both fixed effects. 
Means are shown as white points with 67, 
89% and 95% credibility intervals given in 
decreasing width
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escape phage (Figure 4a,b). In 3, 3 and 4 replicates in the 12-, 24- and 
24-clone (ancestral phage) treatments, respectively, the density of 
the ∆pilA strain dropped to zero (Figure S1), suggesting that hosts 
with CRISPR immunity could occasionally outcompete those with-
out. However, the selection rate of hosts with CRISPR immunity did 
not differ among the polyclonal treatments (F4,113 = 1.73, p = .15; 
Figure 4c). Selection rate also did not change notably over time (re-
gression of selection rate over dpi: β [95% CI] = 0.03 [−0.04, 0.11], 
t(2)118 = 0.94, p = .35) even though phage densities decreased with 
time.
The absence of a detectable relationship between the level of 
CRISPR diversity and the selection rate of hosts with CRISPR im-
munity relative to those without might be because escape phage 
dynamics were dependent on proportion of sensitive bacteria in the 
host population. We hypothesized that the selection rate of sus-
ceptible CRISPR clones relative to resistant CRISPR clones would 
be positively related to the level of CRISPR diversity, because the 
relative frequency of sensitive hosts declines as CRISPR diversity in-
creases. Indeed, in some replicates in the 3- and 6-clone treatments 
the selection rate of the susceptible CRISPR clone was ≤6, indicating 
that they were driven extinct by phage (Figure 5a). Further, the se-
lection rate of susceptible CRISPR clones in these treatments was 
on average less than zero (mean selection rate [95% CI]; 3-clone: 
−1.53 [−2.61, −0.45]; 6-clone: −0.99 [−2.07, −0.09]), indicating they 
tended to be outcompeted by resistant CRISPR clones. Turning to 
the 12- and 24-clone treatments, the selection rate of susceptible 
clones was statistically similar to zero (12-clone: 0.12 [−0.96, 1.21]; 
24-clone: 0.15 [−0.93, 1.24]; Figure 5b,c), and higher than the 3- and 
6-clone treatments (Figure 5b,c). Together, these data show that the 
selection rate of susceptible CRISPR clones increased with CRISPR 
diversity. There was also an increase in selection rate of susceptible 
CRISPR clones over time among polyclonal treatments (regression of 
selection rate over dpi: β [95% CI] = 0.41 [0.03, 0.80], t(2)118 = 2.17, 
p = .03; Figure 5a,b), which parallels the decline in phage popula-
tion sizes over time in the same treatments (regression of ln pfu 
per ml over dpi: β [95% CI] = −2.58 [−3.23, −1.84], t(2)114 = −7.64, 
p = 7.27 × 10−12). These data suggest that susceptible hosts are pro-
tected by population-level CRISPR diversity and that this protection 
is mediated by a reduced ability of phage to replicate on increasingly 
dilute susceptible hosts (Payne, Geyrhofer, Barton, & Bollback, 2018; 
Figure S1).
4  | DISCUSSION
Previous studies have shown that CRISPR diversity can limit the evo-
lution of phage to overcome host resistance (Chabas, et al., 2018a; 
van Houte et al., 2016). In those studies, bacterial populations were 
infected with ancestral phage that had not been previously exposed 
to resistant hosts. Here, we examined the consequences of CRISPR 
diversity once a phage has already evolved to overcome one of the 
CRISPR resistance alleles in the population. This tractable system 
enabled us to closely monitor how the level of CRISPR diversity in-
fluenced the population and evolutionary dynamics of the phage, as 
well as the evolutionary dynamics of the host.
These analyses show that phage population sizes were larger and 
persisted longer in populations with lower CRISPR diversity, which is 
consistent with previous studies (van Houte et al., 2016). Our results 
indicate that phage population size is increasingly limited by host di-
versity, because increasing host diversity reduces the proportion of 
susceptible individuals in the host population. This dilution effect 
of host resistance diversity is an important factor in explaining why 
genetically diverse host populations often have reduced patho-
gen loads (Civitello et al., 2015; Keesing, Holt, & Ostfeld, 2006; 
F I G U R E  3   Phage evolutionary 
emergence was maximized at intermediate 
CRISPR diversity. Estimated proportion of 
phage that had evolved to infect a second 
CRISPR clone in addition to the original 
CRISPR clone they were pre-evolved to 
infect at each day post-infection in each 
polyclonal CRISPR diversity treatment. 
Because these estimates are derived from 
a Bayesian GLMM, they are posterior 
modes—not means—and are shown as 
white points. Similarly, 67, 89 and 95% 
credibility intervals are highest probability 
density intervals and are given in 
decreasing width around mode estimates. 
Raw values from each replicate are shown 
as points
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Ostfeld & Keesing, 2012). The finding that resistant hosts can pro-
tect the susceptible fraction of the population is also consistent 
with the epidemiological concept of 'herd immunity' (Fine, Eames, 
& Heymann, 2011). Whereas herd immunity has been extensively 
studied in eukaryotes, recent work has suggested it may be import-
ant in understanding bacteria–phage dynamics (Payne et al., 2018), 
a suggestion that for which our results provide further experimental 
support. This result also qualitatively matches theoretical predic-
tions of how host diversity should affect pathogen spread in a sys-
tem with matching allele genetic architecture (Lively, 2010).
In theory, this kind of ecological effect can in turn shape the 
evolutionary dynamics of the bacteria–phage interaction, since 
smaller phage population sizes will decrease the mutation sup-
ply and hence the evolutionary potential of the phage (Antia 
et al., 2003; Dennehy et al., 2006; Yates et al., 2006). We did ob-
serve that the evolution of phage host range expansion peaked 
at intermediate levels of CRISPR diversity. This is likely because 
increasing CRISPR diversity dilutes susceptible hosts, which results 
in smaller phage population size and hence less genetic variation on 
which selection can act. Simultaneously, increasing host diversity 
can increase selection for escape mutations. These two effects in 
dynamic tension can maximize evolutionary emergence at inter-
mediate host diversity (Chabas, et al., 2018a). The kind of interde-
pendence between ecological and evolutionary dynamics of phage 
suggested by this study provides important context for other fac-
tors that can affect—and are affected by—evolutionary emergence. 
For example, the ability of a phage to escape a particular CRISPR 
spacer can influence host population structure by determining 
colony heterogeneity (Pyenson & Marraffini, 2020). Another ex-
ample is when CRISPR immunity is incomplete, because phage 
with anti-CRISPR (Acr) genes can vary in the degree to which they 
inhibit the CRISPR immune response (Landsberger et al., 2018). 
Differences in the degree of CRISPR immunity because of Acr di-
versity have been shown to affect the evolutionary emergence of 
F I G U R E  4   Selection rate of bacterial hosts with CRISPR immunity did not increase with CRISPR diversity in polyclonal treatments. 
Selection rate of hosts with CRISPR immunity relative to a strain without CRISPR immunity in (a) the 1-clone CRISPR diversity treatments 
with infective and ancestral phage and (b) the remaining CRISPR diversity treatments. Days post-infection is indicated by colour. Selection 
rate is the natural log of the relative change in density of bacteria with CRISPR immunity (both susceptible and resistant to phage) against 
a strain without. The dotted line at zero indicates no difference in density change; that is, both are equally fit. Box plots show the median, 
25th and 75th percentile, and the interquartile range. Raw values from each replicate are shown as points. (c) Predicted mean selection rate 
is calculated from a GLMM that statistically controls for the effect of time. Means are shown as white points with 67, 89 and 95% credibility 
intervals given in decreasing width
     |  9COMMON et al.
escape phage (Chevallereau et al., 2020). Understanding of how 
these factors interact with CRISPR allele diversity to affect the 
emergence and spread of escape phage will be important in future 
studies of CRISPR ecology and evolution.
In this study, we focussed on host populations where different 
CRISPR resistance genotypes were at equal starting frequencies, 
but natural communities are often composed of a few very common 
and many rare variants (McGill et al., 2007; Pachepsky, Crawford, 
Bown, & Squire, 2001). This likely matters for the observed dynam-
ics, since the proportion of susceptible hosts has a large impact on 
the probability of evolutionary emergence of pathogens (Chabas, 
et al., 2018a). Also, we focussed our analysis on the simple case 
where a diverse host population is infected by a clonal pathogen 
population. In nature, pathogen populations will frequently be 
genetically diverse as well (Hudson, Dobson, & Lafferty, 2006; 
Telfer et al., 2010), and increased levels of pathogen diversity may 
affect the benefits of host diversity (Ganz & Ebert, 2010). Indeed, 
previous studies of CRISPR–phage interactions suggest that in-
fection by two different phages can increase bacteria–phage co-
existence compared to infections with a single phage (Paez-Espino 
et al., 2013, 2015). Further, infection by diverse phage can select 
against CRISPR immunity in favour of surface-based resistance 
at the level of the host population, but also select for individual 
CRISPR clones with a more diverse array of spacers (Broniewski, 
Meaden, Paterson, Buckling, & Westra, 2020). The empirical sys-
tem used in this study offers both a unique ability to link genotypes 
and phenotypes, tight experimental control over the infectivity 
matrix of the host–phage interaction and a clear link with theo-
retical predictions. These features will make it an ideal system for 
more detailed studies to understand how the composition of the 
host population and the relative diversity levels of the phage and 
host shape coevolutionary interactions.
F I G U R E  5   The selection rate of susceptible CRISPR clones increased with CRISPR diversity and over time. Selection rate of the 
susceptible CRISPR clones relative to the resistant CRISPR clones in (a) the 3- and 6-clone CRISPR diversity treatments and (b) the remaining 
CRISPR diversity treatments. Days post-infection is indicated by colour. Selection rate is the natural log of the relative change in density 
of CRISPR clones that were susceptible to phage against CRISPR clones that were resistant to phage. The dotted line at zero indicates 
no difference in density change; that is, both are equally fit. Box plots show the median, 25th and 75th percentile, and the interquartile 
range. Raw values from each replicate are shown as points. The 1-clone treatments, both with infective and ancestral phage, have been 
excluded because all bacterial clones with CRISPR-based resistance in this treatment were susceptible, and the data are therefore present in 
Figure 4a. (c) Predicted mean selection rate is calculated from a GLMM that statistically controls for the effect of time. Means are shown as 
white points with 67, 89 and 95% credibility intervals given in decreasing width
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